Home » » Related Biotechnology, Pharmaceutical and Healthcare News
NEW YORK (Reuters Health) - In high-risk prostate cancer patients treated with dose-escalated radiotherapy, low-dose-rate brachytherapy and androgen-deprivation therapy (ADT) might improve clinical outcome, a retrospective study suggests.
Original Article: Brachytherapy plus ADT helpful...
Related Stories
Blogs
Audio/Video
Press Releases